Rime Bioinformatics
PrivateLast Round
Series A
Jun 11, 2026
Total Funding Raised
$30.89M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Rime Bioinformatics is a biotechnology company that develops bioinformatics software and analytical services to accelerate research into alternatives to antibiotics, specifically focusing on bacteriophage genome annotation.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rime Bioinformatics Comparables
Compare Rime Bioinformatics with similar companies based on industry and business-model similarity.
No public comparables are available for Rime Bioinformatics. Request access to learn about comparables coverage.
Request accessRime Bioinformatics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 11, 2026 | ||||
| Seed | May 29, 2025 | ||||
| Seed | Jun 7, 2023 |
Rime Bioinformatics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Founders You Should Know | Seed |
| Cadenza Ventures | Seed |
| Alumni Ventures | Seed |
| Unusual Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 88% MoM.
- Jun 11, 2026
$22.3M round closed
Rime Bioinformatics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rime Bioinformatics's valuation, stock price, and market status.
Is Rime Bioinformatics a public or private company?
Rime Bioinformatics is a private company.
What is the current stock price of Rime Bioinformatics?
Rime Bioinformatics is a private company with no public stock price. Caplight tracks Rime Bioinformatics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Rime Bioinformatics worth (valuation)?
Valuation information for Rime Bioinformatics is not publicly available.
Can I buy Rime Bioinformatics stock?
Rime Bioinformatics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rime Bioinformatics's last funding round?
Rime Bioinformatics's most recent funding round was Series A on June 11, 2026.
Who are the main investors in Rime Bioinformatics?
Key investors in Rime Bioinformatics include Unusual Ventures.
Will Rime Bioinformatics IPO soon?
No public IPO plans have been announced for Rime Bioinformatics.
How can I track Rime Bioinformatics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rime Bioinformatics's secondary market activity and sign up for updates.